Received Jun 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB044A | — |
maladministration of the diluent only; maladministration of the diluent only; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB044A, expiry date 31-JUL-2025) for prophylaxis. On 12-JUN-2025, the patient received Menveo. On 12-JUN-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: maladministration of the diluent only) and inappropriate dose of vaccine administered (Verbatim: maladministration of the diluent only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 13-JUN-2025 The Vaccine Administration Facility was the same as Primary Reporter A Medical Technician called to report about the maladministration of the diluent only of Menveo vaccine to a patient yesterday which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The Medical Technician wanted guidance if they have to revaccinate the patient.